Ann-Kathrin Dachtler

Allogeneic ABCB5+ Mesenchymal Stem Cells for Treatment-Refractory Chronic Venous Ulcers: A Phase I/IIa Clinical Trial

A. Kerstan, M. Jünger, G. Daeschlein, 2021, JID innovations.

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

S. Sel, B. Ksander, J. Chodosh, 2020, Stem cell research & therapy.